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Introduction
Solitary fibrous tumors (SFTs) are uncommon, 
fibroblastic neoplasms that most often arise in 
middle-aged adults. First described as distinctive 
pleura-specific tumors, SFTs are now known as 
anatomically ubiquitous [1, 2]. Patients are com-
monly asymptomatic, though large tumor size or 
vital structure involvement may lead to local or 
paraneoplastic symptoms such as dyspnea, cough, 
abdominal pain or hypoglycemia [3-7]. The latest 
edition of the World Health Organization (WHO) 
classification of soft tissue and bone tumors consid-
ers hemangiopericytoma as an obsolete synonym of 
SFT [2]. Most SFTs are benign. However, in about 
10% of cases, they are aggressive and may show lo-
cal or distant recurrences even many years after re-
section [2, 6]. The mainstream treatment for SFTs is 
surgery, the benefits of adjuvant radio-chemothera-
py being currently controversial [3-5, 8]. We herein 
present a case series of malignant SFTs of the liver. 
Clinical and histological features of these cases are 
discussed.
Case histories
Case 1: A 74-year-old woman was admitted to hos-
pital with right abdominal pain associated with ab-
dominal distension. Computed tomography (CT) an-
giography showed a well-circumscribed 24 × 16 cm 
mass entirely involving the right lobe of the liver, 
characterized by peripheral enhancement in the ar-
terial phase and dislocated hepatic vessels. Due to 
tumor hypervascularization, a giant hemangioma 
was hypothesized. The patient underwent surgical 
resection of the mass, which was grossly firm, gray-
ish-white, focally myxoid and hemorrhagic, apparent-
ly capsulated. Resection margins were free. Histology 
revealed a lesion composed of spindle and ovoid cells 
arranged in a storiform pattern. Hypercellular areas 
with nuclear crowding, nuclear pleomorphism and 
cytological atypia were observed in different slides 
as well as necrosis. Hemorrhagic areas and increased 
mitotic activity (9 mitotic figures per 10 high power 
fields) were also noted. Immunohistochemically, the 
tumor was positive for vimentin, CD34, STAT6 and 
Bcl-2 but negative for cytokeratins, desmin, CD117, 
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CD99, CD10, platelet-derived growth factor recep-
tors (PDGFR)-α or PDGFR-β. The percentage of 
Ki-67 positive tumor cells was about 40%. Based on 
these results, the tumor was defined as a malignant 
liver SFT. Total body CT scans one, three and five 
months after surgery were unremarkable. However, 
after nine months, multiple nodules (less than 1 cm 
in diameter) were disclosed in the lungs and omen-
tum as well as the mesenteric and abdominal walls. 
Given the suspicion of metastases from the primitive 
malignant SFT, multiple biopsies were performed 
and indeed confirmed this diagnosis histologically. 
The patient subsequently underwent chemotherapy, 
which was unsuccessful, and died six months there-
after.
Case 2: An 80-year-old female patient with dys-
pnea, cough, asthenia and abdominal pain was ad-
mitted to hospital for diagnostic evaluation of a large 
liver hypoechoic mass of the right lobe previously 
detected by regular surveillance ultrasound. The pa-
tient’s surgical history included a right mastectomy 
for a ductal infiltrating carcinoma grade 1. Subse-
quent CT angiography revealed a well-demarked, 
highly vascularized lesion measuring 19 × 15 cm in 
the right hepatic lobe that apparently involved the 
apical segment of the inferior right pulmonary lobe. 
The hepatic vessels, right renal vein and right kid-
ney were dislocated and compressed. An ultrasonog-
raphy (US)-guided biopsy was performed. Histology 
revealed a highly cellular tumor composed of spindle 
cells with evident pleomorphism, high mitotic ac-
tivity (7 or more mitotic figures per 10 high power 
fields), necrosis and hemorrhage. Tumor cells were 
positive for CD34, vimentin, STAT6 and Bcl-2 but 
negative for cytokeratin, desmin, CD117, CD99, 
CD10, PDGFR-α or PDGFR-β. The percentage of 
Ki-67 positive tumor cells was about 30%. The tu-
mor was defined as a malignant liver SFT. Surgical 
resection was not performed due to the tumor’s ex-
tensive occupation of the right hepatic lobe. Multi-
ples nodules were identified in the right lungs and 
histologically confirmed as metastatic lesions. The 
patient subsequently underwent palliative chemo-
therapy and died four months thereafter.
Case 3: A 65-year-old man was admitted to hos-
pital with abdominal discomfort, vomiting and pain. 
Abdominal and chest plain radiograms showed a dis-
location of the right diaphragm and bilateral lung 
nodular shadows. Computed tomography angiogra-
phy revealed a heterogeneous solid mass of 3 × 2 cm 
of the right lobe of the liver with areas of irregular 
enhancement and multiple serpiginous vessels in 
the arterial phase. Vena cava and portal neoplastic 
thrombus were detected as well as multiple and bi-
lateral lung metastases. A US-guided biopsy of the 
liver mass was histologically characterized by spindle 
cells in a collagenous background with areas of high 
cellularity. Cytological atypia, tumor necrosis and in-
creased mitotic rate (6 or more mitotic figures per 
10 high power fields [HPFs]) were noted. The per-
centage of Ki-67 positive tumor cells was about 30%. 
Immunohistochemical results included positivity for 
CD34, vimentin, STAT6 and Bcl-2 but not for cyto-
keratin, desmin, CD117, CD99, CD10, PDGFR-α 
or PDGFR-β. The diagnosis made was a malignant 
variant of SFT of the liver. Multiples nodules were 
identified in both lungs and histologically confirmed 
as metastatic lesions. The patient subsequently un-
Table I. Summarizes clinical and histological features of the three tumors
Case 1 Case 2 Case 3
Age/gender 74/female 80/female 65/male
Tumor size 24 × 16 cm 19 × 15 3 × 2 cm
Hepatic lobe right right right
Necrosis present present present
Hemorrhage present absent absent
Mitotic rate 9 mitoses per 10 HPFs ≥ 7 mitoses per 10 HPFs ≥ 6 mitoses per 10 HPFs
Immunohistochemistry CD34 positive 
vimentin positive 
Bcl-2 positive
CD34 positive 
vimentin positive 
Bcl-2 positive
CD34 positive 
vimentin positive 
Bcl-2 positive
Treatment surgery palliative chemotherapy chemotherapy
Metastases lungs 
omentum 
mesenteric  
and abdominal walls
right lung lungs
Follow-up died 15 months  
after initial surgery
died 4 months thereafter died 5 months thereafter
HPFs – high power fields
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Fig. 1. Malignant solitary fibrous tumor of the liver. Histology (hematoxylin and eosin stain): spindle and ovoid cells, 
hypercellular areas with nuclear crowding, nuclear pleomorphism and cytological atypia (A) intermingled with edematous 
areas containing spindle cells (B) with evident mitosis [Case 1 – HE stain; 20×]. The same type of cells and pattern of 
growth in biopsy specimens (C) [Case 3 – HE stain; 5×]. In Case 3 abdominal and chest radiograms revealed dislocation 
of the diaphragm and bilateral lung nodular shadows (D). CT scan revealed a heterogeneous solid mass with areas of 
irregular enhancement and multiple serpiginous vessels in the arterial phase (E and F)
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derwent chemotherapy, which was unsuccessful, and 
died five months thereafter (Table I, Figs. 1, 2).
Discussion
Solitary fibrous tumors are composed of spindled 
to ovoid cells in a patternless architecture with prom-
inent stromal collagen and hemangiopericytoma-like 
vessels. Some tumors show hypercellularity, nuclear 
atypia, and significant mitotic activity. The latter fea-
ture in particular often portends an aggressive clinical 
course [2]. Only 42 cases of primitive liver SFT have 
been described, and only 4 of those were classified as 
malignant [1]. Although there are no close correlations 
between morphology and malignant behavior, large 
size (more than 5 or 10 cm), sessile lesions, infiltra-
tive margins, hypercellularity, nuclear pleomorphism, 
cytologic atypia, necrosis or hemorrhage and an in-
creased mitotic index (more than 4 mitoses in 10 HPFs) 
have been described in malignant SFTs [1-17].
Histologically, the cases described herein fulfilled 
these criteria. The presence of synchronous, extra-he-
patic metastases in two of the three cases investigated 
(case 2 and case 3) as well as the development of mul-
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Fig. 2. Immunohistochemical profile of malignant solitary fibrous tumors of the liver: the tumor was positive for vimentin 
[A; 20×, Case 1], Bcl-2 [B; 20×, Case 1] and CD34 [C and D; 20×, Case 1 and case 2, respectively]. Marked and diffuse 
Bcl-2 stain in biopsy specimens [E and F; 10×, Case 3]
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tiple metastases during the follow-up period (case 1) 
confirmed lesion malignancy. Another element of 
importance regarding the aggressive nature of ma-
lignant SFTs was demonstrated in case number 1, 
which, despite surgery, had a fatal outcome. Indeed, 
surgery alone proved insufficient therapy even though 
it is often considered the treatment of choice for these 
lesions with the aim of obtaining margin-negative 
specimens.
Computed tomography angiography features were 
similar in all cases studied: large, well-circumscribed 
solid tumors with mixed densities located in the up-
per edge of the right lobe of the liver with periph-
eral enhancement in the arterial phase and multiple 
small serpiginous vessels. No distinctive radiological 
parameters useful in differentiating benign from ma-
lignant liver SFTs are currently known, beyond the 
concomitant presence of extra-hepatic metastasis 
[17, 18]. Positron emission tomography–computed 
tomography using fluorodeoxyglucose (FDG) might 
be potentially useful in differentiating benign from 
malignant SFTs. Song et al. recently demonstrated 
multifocal hepatic lesions with avid FDG uptake in 
a 49-year-old male patient [19].
Postoperative histological examinations encom-
passing complete immunohistochemical panels are 
therefore required for a correct diagnosis of SFT to be 
made. The most characteristic, albeit nonspecific, im-
munohistochemical finding in SFT is CD34 expres-
sion, and more than 90% of SFTs are immunoreactive 
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to CD34 [2, 9]. Nevertheless, characteristic CD34 
reactivity may be absent or only focally present in 
some cases. SFTs may also occasionally express epi-
thelial membrane antigen and smooth muscle actin 
and may rarely label for S100, cytokeratin or desmin 
[2]. Recent molecular analyses have demonstrated 
that almost 100% of SFTs harbor an NAB2-STAT6 
fusion gene, which is considered specific to this tu-
mor type. Recent studies have therefore suggested 
that STAT6 immunohistochemistry is a reliable sur-
rogate for detection of the fusion gene [2, 9]. Doyle 
et al. [2] and Yoshida et al. [9] have demonstrated 
that STAT6 is a highly sensitive and almost perfect-
ly specific immunohistochemical marker for SFT and 
can be helpful to distinguish this tumor type from 
histologic mimics.
In conclusion, we presented a case series of malig-
nant SFTs of the liver, focusing on their clinical and 
histological features. Due to the lack of specific ra-
diological criteria for the diagnosis of malignant SFTs 
in the liver at present, the importance of histological 
examinations is highly recognized, especially in the 
absence of clear evidence of metastases.
Although extremely rare, malignant SFTs should 
be considered in the differential diagnosis of unique, 
isolated hepatic lesions with rich vascular serpiginous 
patterns in radiological imaging. In our opinion, 
when a unique, isolated lesion of the liver is found, 
multiple biopsies should be performed in order to 
have enough material for histological and molecular 
investigations and more thoroughly investigate the 
eventuality of this type of tumor.
The authors declare no conflict of interest.
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